New hope for advanced colon cancer patients in clinical trial
NCT ID NCT05959356
Summary
This study compares two different drug combinations for people with advanced colorectal cancer that has spread and cannot be surgically removed. Researchers want to see if adding a newer immunotherapy drug (envafolimab) to standard chemotherapy and targeted therapy helps control the cancer longer. The trial will enroll 198 adults with specific tumor characteristics who haven't received previous treatment for their advanced cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Cancer Hospital of Guizhou Medical University
RECRUITINGGuiyang, Guizhou, 550000, China
Contact Phone: •••-•••-••••
-
The First People's Hospital of Foshan
RECRUITINGFoshan, Guangdong, 528000, China
Contact Phone: •••-•••-••••
-
The Sixth Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510655, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.